C J Medical India Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.24 M
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 14.65%
- Profit Growth -29726.08%
- Ebitda -251.99%
- Net Worth -46.46%
- Total Assets 5.63%
About C J Medical India
C J Medical India Private Limited (CJMIPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 April 2010 and has a history of 14 years and ten months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.24 M, as per Ministry of Corporate Affairs (MCA) records.
Rajendra Taneja, Charles Reynolds, George Reynolds, and One other member serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U33110TG2010PTC068126
- Company No.
068126
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Apr 2010
- Date of AGM
29 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Healthcare
Who are the key members and board of directors at C J Medical India?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Charles Reynolds  | Director | 28-Apr-2010 | Current |
Rajendra Taneja  | Director | 23-Jan-2017 | Current |
| George Reynolds | Director | 30-Apr-2018 | Current |
| Karthik Annavajjala | Director | 11-Aug-2023 | Current |
Financial Performance of C J Medical India.
C J Medical India Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 14.65% increase. The company also saw a substantial fall in profitability, with a 29726.08% decrease in profit. The company's net worth observed a substantial decline by a decrease of 46.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of C J Medical India?
In 2017, C J Medical India had a promoter holding of 55.39% and a public holding of 44.61%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Quotient Solutions Private LimitedRajendra Taneja is a mutual person
- Onyx Proserve Private Limited
Rajendra Taneja is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at C J Medical India?
Unlock and access historical data on people associated with C J Medical India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of C J Medical India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped C J Medical India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
